Introduction
Maternal cigarette smoking has wide-ranging harmful effects on fetal development and the health of subsequent offspring. These effects include reduced growth (Harvey et al., 2007) , reduced academic achievement (Birney et al., 2006) , increased likelihood of metabolic syndrome (Chen et al., 2006) and reproductive abnormalities and reduced fertility (Weinberg et al., 1989; Jensen et al., 1998 Jensen et al., , 2006 Jensen et al., , 2007 Ramlau-Hansen et al., 2007; Werler, 2007; Ye et al., 2010) . The incidence of smoking has generally fallen over the last 20 years but significant numbers of women continue to smoke before and during pregnancy (Tong et al., 2009) . In Scotland, 31% of women are smokers when first pregnant (Prabhu et al., 2010) and fewer than 4% of these will stop smoking (Tappin et al., 2010) . Smoke exposure in utero remains, therefore, a major cause of adult ill-health and it is essential that we understand the mechanisms leading to altered fetal and post-natal development.
Primordial follicle formation is the single most important event in establishing potential adult fecundity and the timing of menopause in women (Laissue et al., 2008) . In mice, primordial follicle numbers are reduced by exposure to cigarette smoke (Tuttle et al., 2009) , an effect probably mediated by various chemicals, especially polycyclic aromatic hydrocarbons (PAHs), in the smoke (Jurisicova et al., 2007) . PAHs are activating ligands for the aryl hydrocarbon receptor (AHR) and are amongst the active compounds known to affect female reproductive development in rodents (Matikainen et al., 2001) . We have also shown that the fetal human ovary expresses the AHR, its nuclear translocator (ARNT) and that activating the AHR in the human fetal ovary in vitro significantly reduces germ cell proliferation (Anderson et al., 2014) . This highlights a potential mechanism by which maternal smoking may affect female reproductive development but which requires further study. Many women delay childbirth to 35-40 years of age, at which point they will be left with only 5% of their original reserve of non-growing follicles (Wallace and Kelsey, 2010) . It is likely, therefore, that reduced fertility associated with in utero smoke exposure, when combined with delayed childbirth, will result in a significant decline in conception rate.
Given the prevalence of maternal smoking and the exposure of pregnant women to a wide range of environmental chemicals, it is critical that we understand the effects of in utero exposure to chemicals in cigarette smoke on the formation of human primordial follicles (from 18 weeks of gestation onwards (Fowler et al., 2009a) ). We report here that maternal smoking increases the exposure of the female fetus to PAHs, increases fetal circulating estrogens and dysregulates ovarian development and paracrine/endocrine signalling. The evidence suggests that these effects may be mediated through induction of AHR pathways and AHR-estrogen receptor (ESR) crosstalk.
Materials and Methods

Sample collection and study design
The collection of fetal material (Fowler et al., 2008) was approved by the National Health Service Grampian Research Ethics Committees (REC 04/ S0802/21). Women seeking elective, medical terminations of pregnancy were recruited with written, informed consent. Only normally progressing pregnancies from women over 16 years of age and between 11 and 21 weeks of gestation were collected. Fetal ovaries were: (i) snap-frozen and stored at 2858C, (ii) processed for histology or (iii) processed for in vitro culture. The fetal livers were snap-frozen and stored at 2858C. In total, 105 female fetuses were included in this study, 56 from mothers who smoked during pregnancy and 49 from those who did not. Circulating hormones were assayed in a subset of 45 fetuses, with sufficient cardiac blood, and, in a further subset of 22 fetuses, the ovarian expression levels of key developmental genes were determined and liver PAH content measured. In 10 fetuses around 19 weeks of gestation circulating estrogens were measured while 3 further fetuses, from non-smoking mothers, were used for ovary culture to determine ovarian estrogen production (Tables I,  II and III, Figs 1 and 2). The remaining 25 fetuses contributed to the overall assessment of smoke exposure effects on growth.
Hormone and cotinine assays LH, FSH, prolactin (PRL) and intact hCG were measured using DELFIA kits (Fowler et al., 2008 (Fowler et al., , 2009a , with detection limits and inter-and intra-assay Continued coefficients of variation of 0.05 U LH/l, 2.4% and 4.2%, 0.5 U FSH/l, 2.8% and 2.0%, 0.04 mU PRL/l, 2.0% and 3.0% and 0.5 U hCG/l, 4.1% and 4.6%, respectively. Cotinine, a marker of smoking, was measured using a commercial kit (Cozart Plc, Abingdon, Kent, UK), with values of 0 -12 ng cotinine/ml being considered negative (Fowler et al., 2008) . Fetal plasma and ovary-conditioned culture medium samples were assayed for estrogens by gas chromatography linked to mass spectrometry (GC-MS/MS).
The plasma preparation procedure (extraction and purification) used to isolate the target steroids has been previously described (Courant et al., 2007 (Courant et al., , 2010 . Briefly, an enzymatic hydrolysis was followed by purification and partitioning to separate androgens and estrogens. An Agilent 7890A gas chromatograph coupled to a 7000 GC triple-quadrupole device (Agilent, San José, CA, USA) was used for analyte detection and quantification in the selected reaction monitoring acquisition mode. Effects of maternal smoking on the human fetal ovary
Phenotypic investigation of smoking effects on the fetal ovary and immunohistochemistry
Ovarian sections (5 mm) were either stained with hematoxylin and eosin (H&E) or using a Leica BOND-MAX TM automated immunostainer (Leica Microsystems, Newcastle Upon Tyne, UK). The primary antibodies, all with pH 6 antigen retrieval, were: (i) nuclear receptor subfamily 2 group E member 1 (NR2E1): 2 mg/ml: rabbit polyclonal, Abcam (Cambridge, UK), ab30942, (ii) activator of apoptosis harakiri (HRK): 1:50: goat polyclonal, Santa Cruz Biotechnology (Santa Cruz, CA, USA), sc-6972, (iii) major vault protein (MVP): 1:200: mouse monoclonal, Abcam, ab14562, (iv) POU domain, class 1, transcription factor 1 (POU5F1, OCT4): 1:300, goat polyclonal, Santa Cruz, sc-8628, (v) DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 (DDX4, VASA): 1:200: rabbit polyclonal, Abcam, ab13840, (vi) COUP transcription factor 1 (nuclear receptor subfamily 2, group F, member 1: NR2F1): 1:2000: rabbit polyclonal, Abcam, ab96846, (vii) COUP transcription factor 2 (nuclear receptor subfamily 2, group F, member 2: NR2F2): 1:1000: mouse monoclonal, R&D Systems (R&D Systems Europe Ltd, Abingdon, UK), PP-H7147-00. Sections were visualized with Bond 'Refine' 3,3 ′ -diaminobenzidine (DAB), counter-stained with haematoxylin. IgG-negative sections, exposed to non-immune mouse and rabbit or goat serum in the absence of primary antibody, were included in all runs and showed no positive immunostaining. Human fetal ovarian localization for cytochrome P450 scc (CYP11A1) and homeobox protein NOBOX (NOBOX) have previously been reported (e.g. (Huntriss et al., 2006; Fowler et al., 2011) ).
Ovaries from ten 17-to 19-week-old fetuses (five control, five smokeexposed, for details see Supplementary data, Table SI) were scanned using a Zeiss LSM700 and Zen Blue 2012 software and images captured with a Zeiss Mrm camera and visually assessed by a single observer blinded to group identity. The number of (i) primordial follicles and (ii) DDX4, POU5F1 and MVP positive germ cells were determined in single sections (2-4 sections in the case of MVP) and normalized relative to the total area of the relevant sections using ImageJ software.
Western blot
Proteins were extracted from fetal ovaries with Qiagen AllPrep DNA/RNA/ Protein mini kits (Qiagen Ltd, Crawley, UK). Tissue was homogenized in the presence of protease inhibitors (Protease Inhibitor Cocktail, Sigma-Aldrich Company Ltd, Gillingham, UK). Proteins (30 mg/lane) and Odyssey TwoColor molecular weight markers (LI-COR Biosciences UK Ltd, Cambridge, UK) were electrophoresed on a single dimension, 4 -12% Bis-Tris gels (Invitrogen Ltd, Paisley, UK) under reducing conditions and transferred to immobilon-FL membranes (Millipore (UK) Ltd, Watford, UK). Membranes were blocked with Odyssey Blocking Buffer (927-4000: LICor) and incubated with primary antibodies: (i) steroid sulfatase (microsomal), isozyme S (STS): 1:500: rabbit polyclonal, Sigma-Aldrich Company Ltd, Poole, UK, HPA002904, (ii) G protein-coupled estrogen receptor 1 (GPER): 1:1000: rabbit polyclonal, Sigma-Aldrich Company Ltd, HPA027052, (iii) MVP: 2 mg/ml: mouse monoclonal, Abcam, ab14562, (vi) NR2F1: 1:500: rabbit polyclonal, Abcam, ab96846. Protein bands were visualized using an Odyssey infrared fluorescence imager (LI-COR) and analysed using TotalLab TL120 software (v2008.1; Nonlinear Dynamics Ltd, Newcastle upon Tyne, UK) (see (O'Shaughnessy et al., 2011) ).
Ovarian estrogen production
Three human fetal ovaries from control fetuses (Table I) were dissected free of other tissues, and then cut longitudinally and transversely. Tissue pieces were placed on cell culture inserts (PICM ORG 50, Millipore UK Ltd), each well receiving half an ovary. The cells contained 1 ml Waymouth media (Fisher Scientific UK Ltd, Loughborough, UK) supplemented with ITS+ (BD Biosciences), penicillin/streptomycin (Sigma-Aldrich), pyruvic acid (Merck) and follistatin (0.4 mg/ml, R&D Systems Europe Ltd, Abingdon, UK). Fetal ovary pieces were cultured at 378C in 5% C0 2 and the media was replaced every 48 h. Culture medium representing 1 -48 and 49 -72 h culture periods were used for estrogen assay. 
PAH determinations
The fetal liver concentrations of 16 PAHs known to be in cigarette smoke were determined as previously described (Fowler et al., 2008) . Briefly, seven internal standards (0.05 mg) were added to freeze-dried livers and PAHs extracted and quantified using GC/MS operated in the single ionmonitoring mode (Thermo Electron Trace MS (Hemel Hempstead, UK) linked to a Trace 2000 GC fitted with an AS2000 auto-sampler).
Real-time quantitative PCR (qPCR, Supplementary data, Table SII) For quantification of specific mRNA species in fetal ovaries (see (Fowler et al., 2009a (Fowler et al., ,b, 2011 ), qPCR was used after reverse transcription of isolated RNA (see (O'Shaughnessy et al., 2007) ). To allow specific mRNA levels to be expressed per ovary, 5 ng external standard (luciferase mRNA: Promega UK, Southampton, UK) was added to each ovary at the start of the RNA extraction (Baker and O'Shaughnessy, 2001) . Ovarian RNA was extracted using TRIzol (Life Technologies, Paisley, UK). The real-time PCR approach utilized the SYBR green method using a Stratagene MX3000 cycler. The quantity of each measured cDNA from the real-time PCR was expressed relative to the standard luciferase cDNA in the same sample. Transcripts were selected from our own gene array study of primordial follicle formation (Fowler et al., 2009a) and from the literature.
Data analysis
Statistical analyses of data were performed using JMP 9.0.2 software (Thomas Learning, London, UK). Normality of data distribution was tested with the Shapiro-Wilk test and non-normally distributed data were log-transformed and re-checked for normality prior to analysis by analysis of variance (ANOVA) and Tukey-Kramer honest significant difference test. Care was taken to ensure that groups were balanced in terms of fetal age. Because most of the parameters investigated showed developmental changes in expression across the second trimester, two-way ANOVA was used to test the combined effects of gestational age (weeks) and maternal smoking (yes/no) on morphological and biochemical data and gene expression levels. A statistically significant increase in variation in the smoke-exposed group and a reduced correlation between transcript levels and weeks of gestation (two-way ANOVA: interaction between smoking and weeks of gestation, P , 0.05) was observed for four transcripts. This statistically significant disturbance of transcript expression patterns across the second trimester is described as dysregulation. Levene's test was used to probe the significance of differences in variances between control and smoke-exposed groups.
Bioinformatics
Following on from our previous study (Anderson et al., 2014) showing AHR expression in the late first and second trimester human fetal ovary and AHR-induced reduction in late first trimester human fetal ovary, we utilized a combined literature search and IPA pathway analysis strategy to look for further AHR target genes. Data mining and bioinformatics were carried out using the University of California and Santa Cruz (UCSC) genome browser (http://genome.ucsc.edu/index.html). Analysis was carried out using the Human Mar. 2006 (NCBI36/hg18) assembly. Highlighted binding sites have been conserved between humans and rodents (75 million years of divergent evolution) and calculated using the Transfac Matrix Database (v7.0) set at its most stringent setting (Z score cut-off ¼ 2.33).
Results
Maternal cigarette smoking does not significantly affect gross female fetal morphology
There were no significant morphological differences between control and smoke-exposed groups and no statistically significant interaction Table I . In (C) and (D), linear regression fits (based on the 22 fetuses of the qPCR/PAH group shown in Table I ) are shown by solid (control) or dashed (smoke-exposed) lines and 95% confidence limits by solid (control) and stippled (smoke-exposed) shading.
between weeks of gestation and maternal cigarette smoking (Table I) Maternal cigarette smoking disturbs female fetal endocrine signalling
Both estrone (E1) and estradiol (E2) concentrations were extremely high in the fetal circulation and were further increased (2-to 3-fold) by maternal smoking (Fig. 1A , Table I ). In cultured ovaries (Fig. 1B) of fetuses from non-smoking women, E1 release was significantly less than E2 release, with an E1:E2 ratio (0.35 + 0.11) much lower than that in the fetal circulation, where E1 was dominant (E1:E2 ratio ¼ 2.0 in control and 2.9 in smoke-exposed fetuses). Mean levels of transcripts encoding the estrogen receptor 2 (ESR2) were not affected by maternal smoking (Table II) but separate analysis of active and dominant-negative ESR2 isoform transcripts (Table II , Fig. 1C ) showed that maternal smoking altered the ratio of active/dominant negative transcripts so that variance was significantly altered (Levene's test, P ¼ 0.022). Within the smoke-exposed group, five fetuses showed a marked shift in balance between the two types of isoforms, favouring expression of transcripts encoding the active receptor isoform. Putative estrogen detection may also occur through GPER, although most ovaries did not have detectable levels of transcripts (Fig. 1D , Table II ). Expression of STS (Fig. 1E ) in the fetal ovary increased across the second trimester showing that the ovary can probably de-conjugate estrogens although there was no effect of maternal smoking (Table II) . Maternal smoking was, however, associated with a significant 1.7-fold increase in the intra-ovarian Inhibin bA/inhibin a ratio (INHBA/INHA) transcript ratio (Fig. 1F) , which would tend to shift the balance from inhibin towards activin signalling. Circulating LH and FSH ( Fig. 2A) significantly increased across the second trimester but PRL (Fig. 2B) showed no trend and intact hCG decreased (Fig. 2B) . Maternal smoking did not significantly affect fetal LH, FSH, PRL or hCG (Table I) or endocrine receptor transcripts (Tables I and II) . The statistically significant increase in FSH receptor (FSHR) across the second trimester seen in control ovaries (Fig. 2C) was, however, not observed in smoke-exposed ovaries (Fig. 2D) .
Maternal cigarette smoking disturbs oocyte/ follicle progression in the second trimester human fetal ovary
In ovaries from fetuses averaging 18 weeks of gestation (see Supplementary data, Table SII) there was an increase in primordial follicle number in smoke-exposed fetuses (Fig. 3A) . In the same group there was also an increase in DDX4+ve oocyte number although there was no smoke exposure effect on the numbers of POU5F1+ve oocytes between the two groups (Fig. 3C) . MVP in the human fetal ovary is oocyte-specific and both MVP transcript and protein increased markedly across the second trimester (13.4-fold from 11 -3 to 17-21 weeks of gestation: Fig. 3E and F) . However, transcript levels and the number of MVP+ve oocytes were not significantly affected by maternal smoking (Table II, Fig. 3G ).
Maternal cigarette smoking dysregulates key fetal ovarian transcripts
Most of the 58 ovarian transcripts investigated (Table II) showed no statistically significant effect of maternal smoking (e.g. follistatin [FST] ). Considerable inter-fetus variation precluded statistical significance for some transcripts with large differences between means (e.g. POU5F1). Four fetal ovarian transcripts (cytochrome P450 scc [CYP11A1], homeobox protein NOBOX [NOBOX], HRK, NR2E1), however, showed significant dysregulation with smoke exposure (Fig. 4) . The dysregulation manifested as a statistically significant increase in variation in the smoke-exposed group and a reduced correlation between transcript levels and weeks of gestation (2-way ANOVA: interaction between smoking and weeks of gestation, P , 0.05). No statistically significant dysregulation was observed for other ovarian transcripts or any other measures from either the whole population or subpopulations detailed in Table I (e.g. body weight, hormone profiles). This indicates that the smoke exposure-associated disturbance of these four transcripts is not due to sample selection or effects on fetal growth rates. NR2E1 ovarian transcript levels ( Fig. 4E) were also significantly higher in smoke-exposed fetuses ,16 weeks old. NR2E1 protein was localized to somatic cell nuclei and was absent from most germ cells. Most pre-granulosa cells in primordial follicles showed strong NR2E1 staining, which was also seen in many somatic cells around nests. Mesenchymal cell streams were mostly NR2E1 negative (Fig. 4F) . HRK protein was localized to scattered germ cells, especially those in nests while those enclosed in primordial follicles were mostly HRK-negative (Fig. 4D ).
Maternal cigarette smoking increases female fetal liver PAH content
Overall liver PAHs were significantly higher in smoke-exposed livers than control livers (5.8-fold, P ¼ 0.011, Table III ). Pyrene, benzo[k]fluoranthene and benzo[a]pyrene were only detectable in smoke-exposed fetuses while acenaphthalene was detectable only in controls. Benzo[a]anthracene concentrations showed no change as a result of maternal smoking, while chrysene was 323-fold higher in control livers although extremely variable between fetuses. Of the 10 PAHs that were detectable in both groups, 8 were between 1.3-fold and 35.8-fold higher in smoke-exposed fetuses, although only fluorene (11.2-fold, P ¼ 0.021) and phenanthrene (6.5-fold, P ¼ 0.025) reached statistical significance.
NR2F1, an AHR target gene, is a candidate mediator the effects of maternal smoking on the fetal ovary Fifteen AHR target genes were further investigated, based on known or possible roles in ovarian development and xenochemical detection or metabolism (Table IV) . NR2F1 was significantly dysregulated (P ¼ 0.021) and increased (P ¼ 0.026) in smoke-exposed fetuses (Fig. 5A , Table IV ). The closely related NR2F2 was not affected by maternal smoking (Fig. 5B) . Expression of NR2F2 was nuclear in ovarian somatic cells and testis Leydig and peritubular myoid cells (labelled inset, Fig. 5C and D) , but the protein was also located in the cytoplasm of some oocytes earlier in gestation and then also in the nuclei of some oocytes at later stages. The major band recognized by the NR2F1 Figure 3 Maternal cigarette smoking affects fetal human ovarian germ cell development at 17-21 weeks of gestation. Smoke-exposed fetal ovaries have a higher density of primordial follicles (A, B) as well as an increased density of DEAD box protein 4 (DDX4)+ve oocytes (C). In contrast, neither POU domain, class 1, transcription factor 1 (POU5F1)+ve (C) nor major vault protein (MVP)+ve (G) oocyte densities were affected by maternal smoking. MVP expression increases sharply across the second trimester (E, F). MVP was localized to oocyte cytoplasm (F, G) although expression prior to 17-21 weeks was very infrequent and faint. Even at 19 weeks and later there were many MVP-ve oocytes visible. In (D), (F) and (G), the stain is DAB (brown) and counterstain is haematoxylin, visualized by brightfield view. The inset panels show the absence of staining in IgG-negative (non-immune serum) controls. In (B) the black arrow highlights a primordial follicle, the white arrow a mesenchymal cell stream and the grey arrow an oocyte nest while in (D), (F) and (G), black arrows denote +ve staining, white arrows -ve stain.
antibody on a western blot (Fig. 5D ) was at 46 kDa as expected. Of the other two major xenosensors, nuclear receptor subfamily 1 group I member 2 (NR1I2 [PXR]) transcript was detected in most ovaries and unaffected by maternal smoking while nuclear receptor subfamily 1 group I member 3 (NR1I3 [CAR] was detected in a high proportion of control ovaries (Fig. 5E , Table IV ).
Figure 4
In utero smoke exposure dysregulates expression of key ovarian transcripts. Dysregulation is defined as a statistically significant increase in variation in the smoke-exposed group and a reduced correlation between transcript levels and weeks of gestation (assessed by two-way ANOVA: interaction between smoking and weeks of gestation, P , 0.05): (A) cytochrome P450 scc [CYP11A1] (controls: log CYP11A1 ¼ 26.03 + 0.47*weeks, P , 0.001; smoke-exposed: log CYP11A1 ¼ 22.65 + 0.25*weeks, P ¼ 0.013), (B) homeobox protein NOBOX [NOBOX] (controls: log NOBOX ¼ 220.28 -+ 1.30*weeks, P , 0.001; smoke-exposed: log NOBOX ¼ 211.49 + 0.78*weeks, P ¼ 0.013), (C) activator of apoptosis harakiri [HRK] (controls: log HRK ¼ 25.71 + 0.38*weeks, P , 0.001; smoke-exposed: log HRK ¼ 22.13 + 0.17*weeks, P ¼ 0.021), (E) nuclear receptor subfamily 2 group E member 1 [NR2E1] dysregulation (controls: log NR2E1 ¼ 2.05 + 0.18*weeks, P ¼ 0.008; smoke-exposed: log NR2E1 ¼ 2.28 + 0.16*weeks, P ¼ 0.022) is very similar to that shown for HRK and therefore not shown. However, younger fetuses demonstrate clear smoke-induction of NR2E1, with histograms and error bars denoting mean + SEM. In (A) -(C) linear regression fits are shown by solid (control) or dashed (smoke-exposed) lines and 95% confidence limits by solid (control) and stippled (smoke-exposed) shading. Controls are shown by white circles/bars, smoke-exposed by grey circles/bars. (D) HRK was localized to scattered germ cells while most germ cells in primordial follicles were HRK-negative. HRK was also localized in some somatic cells, especially pre-granulosa cells associated with primordial follicles (inset). (F) NR2E1 was localized to somatic cell nuclei and absent from germ cells. Most pre-granulosa cells in primordial follicles showed strong NR2E1 staining as did many somatic cells around nests. In (D) and (F) the stain is DAB (brown) and counterstain is haematoxylin, visualized by brightfield view. The inset panels show the absence of staining in IgG-negative (non-immune serum) controls. Black arrows denote +ve staining, white arrows -ve stain.
We also interrogated the UCSC Genome Bioinformatics Website to trawl for AHR-related transcription factor binding sites ( Table V) and found that of the maternal-smoking dysregulated genes CYP11A1 had a conserved AHR/ARNT binding site, as did FSHR and NR2F1. Furthermore, NR2E1, CYP11A1 and FSHR all had NR2F1 binding sites.
Discussion
This extensive study shows that exposure to the complex mixture of chemicals in cigarette smoke disturbs human fetal ovarian development in utero and increases the fetal burden of AHR-activating chemicals. The significance of this is highlighted by our demonstration that in vitro activation of AHR reduces human fetal ovarian germ cell proliferation. We also show that the female human fetus is normally exposed to very high levels of endogenous estrogens, which markedly increase if the mother smokes. Overall, our findings suggest, for the first time, that prenatal maternal cigarette smoking induces AHR activation, dysregulates genes important in ovarian development (including inhibin/activin and FSH signalling), reduces germ cell proliferation and elevates estrogen exposure in the human. We propose that these changes probably contribute significantly to the observed reduced fecundity in women exposed to cigarettes prenatally (Ye et al., 2010) .
Our data on maternal smoking effects on primordial follicle number and number of DDX but not POU5F1 positive oocytes clearly support the conclusion that primordial follicle formation is dysregulated in smoke-exposed fetuses. Nevertheless, the relatively small sample size of five ovaries/group and low number of primordial follicles in the population available means that this finding needs to be confirmed in a larger study, especially one using full stereological techniques to count oocytes and follicles. However, it must be noted that the data are internally consistent with increased primordial follicle number associated with increased DDX4 positive oocytes, which would be expected . Previous studies suggest that cigarette smoke PAHs, which are AHR ligands, disturb ovarian development (Jurisicova et al., 2007; Tuttle et al., 2009 ) and here we report significantly increased PAH concentrations in livers of female fetuses exposed to maternal cigarettes. Numerous reports exist of adverse effects of AHR ligands on reproductive development and function (e.g. Sobinoff et al., 2011) ) and the trend for dysregulated AHR:ARNT transcript ratios in the smoke-exposed fetal ovaries (Table II , P ¼ 0.057) suggests alteration in AHR signalling. Further studies are required, however, to relate agonist bioactivity to levels in human fetuses. In the female human fetus, cigarette exposure is linked to decreased germ cell and somatic cell numbers (Lutterodt et al., 2009; Mamsen et al., 2010) . Furthermore, the reduced germ cell proliferation we previously reported in fetal ovaries ......................................................................................................................................................... .....
Table IV
Effects of maternal cigarette smoking on the mRNA transcript levels of selected AHR responsive/target genes and/or matching binding sites on genes identified in Table II and Fig. 4 expression in the fetal ovary. Dysregulation is defined as a statistically significant increase in variation in the smoke-exposed group and a reduced correlation between transcript levels and weeks of gestation (assessed by two-way ANOVA: interaction between smoking and weeks of gestation, P , 0.05): (A) NR2F1 (controls: log NR2F1 ¼ 25.35 + 0.43*weeks, P ¼ 0.006; smoke-exposed: log NR2F1 ¼ 0.33 + 0.11*weeks, P ¼ 0.147), (B) NR2F2 (controls: log NR2F2 ¼ 2.05 + 0.18*weeks, P ¼ 0.008; smoke-exposed: log NR2F2 ¼ 2.28 + 0.16*weeks, P ¼ 0.022). In (A) and (B) linear regression fits are shown by solid (control) or dashed (smoke-exposed) lines and 95% confidence limits by solid (control) and stippled (smoke-exposed) shading. Controls are shown by white circles/bars, smoke-exposed by grey circles/bars. NR2F1 was localized (C) to the cytoplasm of some oocytes and the nuclei of scattered somatic cells earlier in the second trimester but later was also expressed in the nuclei of some oocytes and in some somatic cells, including some pre-granulosa cells. Many mesenchymal cell streams were NR2F1 2ve. In the testis NR2F1 was localized predominantly to Leydig cell nuclei. NR2F2 (D) was localized to the nuclei of many somatic cells, including mesenchymal cell stream nuclei, and also to smaller oocytes. NR2F2 was also localized in some pre-granulosa cell nuclei and predominantly in Leydig and peritubular myoid cell nuclei in the testis. In (C) and (D) the stain is DAB (brown) and counterstain is haematoxylin, visualized by brightfield view. The inset panels show the absence of staining in IgG-negative (non-immune serum) controls or, if labelled 'Testis', show matching expression in the second trimester human fetal testis. Black arrows denote +ve staining, white arrows -ve stain. The xenosensor nuclear receptor subfamily 1 group I member 2 (NR1I2 [PXR]) (E) was detectable in most ovaries examined but was not affected by maternal smoking. In contrast the xenosensor nuclear receptor subfamily 1 group I member 3 (NR1I3 [CAR]) (E) was detectable in few ovaries and was significantly reduced by maternal smoking.
Effects of maternal smoking on the human fetal ovary cultured with an AHR-activating ligand (Anderson et al., 2014) would be a key component in disturbing the germ/somatic cell balance that underpins appropriate primordial follicle formation in the developing ovary. Levels of fetal circulating estrogens measured in the present study were very high and markedly greater than those reported previously (Shutt et al., 1974; Smith et al., 1975) . The reason for this discrepancy is not clear but the early studies used an indirect competitive protein binding assay method that does not give information on the analyte identity. In their detailed review of more recent studies Kuijper et al. (2013) assembled data from a number of studies reporting similarly high female fetal estrone and estradiol levels, supporting our findings reported here. The fetal estrogen levels reported here are also markedly higher than those in the maternal circulation (Holl et al., 2009) . During pregnancy the placenta is the main source of estrogens and differences between fetal and maternal estrogen levels are probably due to concentration effects of placental estrogens passing into the much smaller fetal blood volume. In pregnant women estrogen levels are decreased and androgen levels are increased by smoking (Bernstein et al., 1989; Toriola et al., 2011) . The different response to smoking in the fetus is probably related to altered steroid metabolism by the mother, placenta and fetus. Increased fetal estrogen is likely to be due to increased placental production, conjugation and protein binding in the fetus. In addition, human fetal ovarian and hepatic cytochrome P450 aromatase (CYP19A1) (Fowler et al., 2009a ; O'Shaughnessy et al., 2013), which converts androgen to estrogen, will probably contribute to elevated estrogens in smoke-exposed fetuses. Our data shown here, combined with the steroid machinery reported in Fowler et al. (2009a Fowler et al. ( , 2011 , strongly suggest that the fetal ovary itself may be a major contributor to intra-ovarian estrogen titres.
The increased INHBA:INHA sub-unit ratio in smoke-exposed ovaries would be expected to increase activin A, which is expressed in germ cells immediately prior to follicle formation (Martins da Silva et al., 2004) . Indeed, administration of activin to neonatal mice during the period of nest breakdown and primordial follicle formation significantly increases the number of primordial follicles formed (Bristol-Gould et al., 2006) . Activin A suppresses Kit ligand (KITLG) expression in adjacent somatic cells, part of the system regulating the timing of follicle formation (Coutts et al., 2008; Childs and Anderson, 2009 ), thus providing a mechanism for an effect on subsequent female fertility. The absence of changes in circulating gonadotrophins in female fetuses exposed to maternal smoking agrees with male data (Fowler et al., 2008 (Fowler et al., , 2009b , although LH and FSH were higher in female than male fetuses (up to 4.8-fold, P , 0.001). The latter sex difference is likely to be due to negative feedback by testosterone in the male fetuses.
In many species E2 reduces primordial follicle formation but, in the human, the fetal ovary can produce high levels of E2 (present study) and primordial follicle formation occurs in the presence of high fetal and maternal estrogen levels. In some model species, FSH is required for primordial follicle formation (e.g. hamsters (Roy and Albee, 2000; Wang and Roy, 2004) ) and the high levels of FSH in the female fetal circulation reported here would be consistent with this mechanism in the human. While circulating fetal FSH is unaffected by maternal smoking, the pronounced trend for reduced FSHR expression (a similar effect of smoking was reported in a study published in Polish for granulosa cell FSHR in women (Josiak et al., 2006) ) and lack of increasing FSHR expression with gestational age (Table II , Fig. 2C and D) suggests that adverse effects of smoking on primordial follicle formation may occur via altered FSH signalling. In hamsters, FSH-regulated, ovary-produced E2 is critical for germ and somatic cell survival and differentiation, thereby underpinning primordial follicle formation, but this effect is lost when E2 levels rise beyond a threshold (Wang and Roy, 2007) . Since in utero exposure of women to diethylstilbestrol (DES) is associated with an increased risk of infertility and early menopause (Hoover et al., 2011) , high circulating and intra-ovarian estrogens, together with a reduced proportion of ovarian dominant-negative ESR2 isoforms (in nearly half of smoke-exposed fetuses reported here), support the hypothesis that excessive estrogenic signalling will impair human fetal folliculogenesis. The fetal baboon, like the human , also expresses ESR2 in fetal oocytes (Bocca et al., 2008) and, using experimental approaches impossible in the human, multiple roles of estrogen in the fetal baboon ovary have been identified. These include the regulation of a-inhibin , folliculogenesis (Zachos et al., 2002; Billiar et al., 2003; Pepe et al., 2006) , FSHR expression and oocyte proliferation Burch et al., 2009) . Furthermore, estrogen deprivation does not alter levels of mothers against decapentaplegic homolog (SMAD)-transducing activin signalling, suggesting that estrogen regulates fetal baboon folliculogenesis by modulating the intra-ovarian activin:inhibin ratio (Billiar et al., 2004) . This is identical to one of the effects reported here for maternal smoking: a significant alteration in activin:inhibin transcript ratio. Such an alteration might be expected to exert negative effects on human follicle formation (Coutts et al., 2008; Childs and Anderson, 2009 ). We had previously observed a decrease in MVP protein in fetal sheep exposed to a complex cocktail of environmental chemicals (Bellingham et al., 2013) and therefore investigated MVP in the human fetal ovary. However, transcript levels and the number of MVP+ve oocytes were not significantly affected by maternal smoking, suggesting differences in the affected ovarian pathways between the human and the sheep model. Smoke exposure dysregulated expression of four fetal ovarian transcripts (CYP11A1, HRK, NR2E1, NOBOX), each of which may play a role in normal follicle formation and development. Dysregulation of CYP11A1 (which is localized in oocytes ), for example, suggests smoke exposure will affect ovarian steroidogenesis. Similarly, PAH exposure negatively affects the primordial follicle pool in mice by inducing HRK in the presence of apoptosis regulator Bax (BAX) (Matikainen et al., 2001; Jurisicova et al., 2007) and HRK is mostly expressed in the oocytes and pre-granulosa cells associated with primordial follicles in the fetal human ovary. Dysregulation and increased expression of the transcriptional repressor NR2E1 in ,16-week-old human fetal ovaries exposed to cigarettes (present study) may be related to the induction of POU5F1 expression (transcript levels nearly doubled by maternal smoking, Table II ) through activation of AKT signalling (Chavali et al., 2011) . This is important since the AHR ligand 7,12-Dimethylbenz(a)anthracene (DMBA) causes ovotoxicity in mice by activating PI3K/AKT and mTOR signalling pathways (Sobinoff et al., 2011) and maintenance of POU5F1 in fetal germ cells would disrupt primordial follicle formation . Deficits in the oocyte-specific transcript NOBOX leads to impaired somatic-germ cell communication and somatic cell invasion during ovarian development (Lechowska et al., 2011) . Dysregulated NOBOX would be expected, therefore, to contribute to impaired germ cell nest breakdown and thereby alter primordial follicle formation.
Dysregulation of the AHR-responsive transcription factor NR2F1 and the presence of highly conserved AHR/ARNT and/or NR2F1 binding sites on the genes for NR2E1, CYP11A1 and FSHR are highly suggestive of adverse consequences of AHR activation on the human fetal ovary through several pathways. Firstly, NR2F1 (and NR2F2) is a repressor of FSHR in gonadal cells (Xing et al., 2002) . The cytoplasmic as well as nuclear expression of NR2F1 has previously been reported (Tang et al., 2005) . In contrast, the related transcription factor NR2F2, which has been proposed as part of the mechanism leading to masculinization disorders (van den Driesche et al., 2012) , was unaffected in the human fetal ovary. Dysregulated NR2F1 expression and AHR activation, as a result of maternal smoking, may therefore contribute to the disconnection between gestational stage and FSHR expression. Secondly, the trend towards increased NR2F1 may also disturb retinoic acid signalling (Zhuang and Gudas, 2008) , with potential disruption of the coordination of meiosis entry, which is important in the fetal ovary (Childs et al., 2011) . Lastly there is also evidence linking NR2E1, NR2F1, FSH and the developmental/transcription regulator B-cell CLL/lymphoma 11A (zinc finger protein) (BCL11A), with the pathways considered important in oocyte-granulosa cell interactions (Perlman et al., 2006; Chan et al., 2013) .
Based on a synthesis of our data and the supporting literature we propose a model (Fig. 6 ) in which disturbed coordination of a complex sequence of events from nest breakdown to primordial follicle formation, via several pathways, will impair ovarian development of some, but not all, fetuses. Increased estrogen and activin signalling and AHR-activating ligands (e.g. PAHs) and reduced FSH signalling would be expected to alter the coordination of pathways leading to primordial follicle formation. The disturbed balance between proliferation and apoptosis is likely to contribute to reduced numbers of germ and somatic cells and impact negatively on primordial follicle formation. Dysregulation of CYP11A1 would be expected to affect the pattern of steroidogenesis within forming primordial follicles. Altered expression of the somatic cell orphan receptor NR2E1 may increase transcription repression and activate AKT signalling prior to the start of primordial follicle formation. At the same time, dysregulated expression of NOBOX and a shift in the intra-ovarian inhibin/activin signalling balance in favour of activin A would probably disturb germ cell nest breakdown and the synchronization of primordial follicle formation. Early inhibition of AMH by elevated E2 might also disrupt the timing of primordial follicle formation (Grynberg et al., 2012) . The observation that maternal smoking alters specific transcript levels in some individuals and not others is likely to contribute to the changed incidence of reduced fertility: i.e. some individuals are affected but not all. Finally, activation of the AHR might modulate estrogen actions, potentially increasing anti-estrogenic effects of AHR ligands in cigarette smoke through ESR2 mediation of ARNT co-activation (Swedenborg and Pongratz, 2010) . Overall, it is also likely that altered NR2F1 plays an important role in these processes. These hypotheses are based on a relatively large number of samples but given the large individual variation in response to maternal Figure 6 Diagram summarizing dysregulation of fetal ovarian development and primordial follicle formation by maternal cigarette smoking. Increased circulating estrogen in the presence of high intra-ovarian estradiol (E2) and aryl hydrocarbon receptor (AHR) activation would lead to reduced proliferation and dysregulation of activator of apoptosis harakiri (HRK)-mediated apoptosis. Disturbed nuclear receptor subfamily 2 group E member 1 (NR2E1) and COUP transcription factor 1 (NR2F1) may be expected to increase transcription repression and PI3K/ACT and mTOR signalling, especially prior to 16 weeks gestation. Dysregulated homeobox protein NOBOX (NOBOX) and FSH receptor (FSHR) is likely to affect germ cell nest breakdown while dysregulated germ cell CYP11A1 may affect steroidogenesis. Increased activation of estrogen receptor b (ESR2) (partly by reduced relative dominantnegative ESR2 isoforms in some smoke-exposed ovaries) may lower intra-ovarian anti-Mullerian hormone (AMH), which, together with a shift in intra-ovarian inhibin/activin signalling towards activin, would desynchronize primordial follicle formation. smoking, they will need to be followed up by more detailed mechanistic studies with greater power.
In summary, these data provide a possible mechanistic explanation of how maternal cigarette smoking may negatively impact the human female fetus, explaining the link between maternal smoking and reduced fecundity in daughters. Maternal cigarette smoking during pregnancy causes significant dysregulation of key fetal ovarian genes and endocrine signalling during the second trimester, partly driven by an increase in the liver burden of AHR-activating ligands, PAHs.
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Supplementary data are available at http://humrep.oxfordjournals.org/.
